Clinical Trial: Observational Study In Real Life Settings Of The Systemic Treatment Of Well Differentiated, Unresectable Or Metastatic, Progressive Pancreatic Neuroendocrine Tumors (pNET): A Study Of Morbidity And Mortality At 2 Years
Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational
Official Title: Observational Study In Real Life Settings Of The Systemic Treatment Of Well Differentiated, Unresectable Or Metastatic, Progressive Pancreatic Neuroendocrine Tumors (Pnet): A Study Of Morbidity And Mo
Brief Summary: A descriptive, prospective (partly retrospective), multisite, observational study conducted in France in adult patients treated for a well differentiated, unresectable or metastatic, pancreatic neuroendocrine tumor with disease progression.
Detailed Summary: prospective and retrospective Analyses will be performed using SAS® software
Sponsor: Pfizer
Current Primary Outcome: Progression-Free Survival (PFS) [ Time Frame: at baseline, each 3 to 4 months up to 2 years ]
Original Primary Outcome: Same as current
Current Secondary Outcome: Overall Survival (OS) [ Time Frame: baseline, each visit up to 2 years ]
Original Secondary Outcome: Same as current
Information By: Pfizer
Dates:
Date Received: September 2, 2014
Date Started: May 12, 2015
Date Completion: June 5, 2019
Last Updated: May 22, 2017
Last Verified: May 2017